IP Library Granted Patent US 7,074,812
Granted Patent B2
US 7,074,812 · App. 10/633,325 · Granted Jul 11, 2006

Development of muscle mass in a mammal

Assignee: Nutraleutical Development Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,074,812
App. No.
10/633,325
Granted
Jul 11, 2006
Kind
B2
Abstract

In a method of developing muscle mass in a mammal, nicotine or nicotine acetylcholine receptor agonist (nAChR) is administered in combination with exercise to stimulate, recruit and mobilize muscle cells to a specific muscle mass.

Claims (9)

1. A method of developing muscle mass in a mammal by stimulating, recruiting and mobilizing muscle cells to a specific muscle mass, the method comprising administering nicotine or nicotine acetylcholine receptor agonist (nAChR) to a mammal in an amount sufficient combined with exercise to increase said specific muscle mass.

2. The method of claim 1 wherein the muscle cells are differentiated from endogenous stem cells.

3. The method of claim 1 wherein said muscle cells are recruited to said specific muscle mass in response to said exercise of said specific muscle mass.

4. The method of claim 3 wherein said exercise stimulates the muscle cells of said specific muscle mass to express nicotinic acetylcholine receptors.

5. The method of claim 4 including the step of administering nicotine or a nAChR agonist to bind said nicotinic acetylcholine receptors.

6. The method of claim 5 wherein said binding stimulates the release of growth factors, including human growth hormone (HGH), vascular endothelial growth factor (VEGF), basic fibroblast growth factors (bFGF) and other chemokines, cytokines and attractants to stem cell recruitment, migration and mobilization at said specific muscle mass.

7. The method of claim 2 wherein said stem cells differentiate into the phenotype of said specific muscle mass.

8. The method of claim 3 wherein said exercise stimulates said specific muscle mass to release metabolites, catecholamines, cytokines, chemokines, and/or cause an inflammatory response in said specific muscle mass.

9. The method of claim 1 wherein the nicotine or nicotine acetylcholine receptor agonist (nAChR) is administered in an amount sufficient to produce increased thermogenesis.

Assignments (3)
CHANGE OF NAME Recorded Apr 24, 2018
From: SOMA NUTRACEUTICALS, INC.
To: SOMACEUTICALS, INC.
Reel/Frame 046011/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2018
From: SUMMERS, DAVID P
To: SOMA NUTRACEUTICALS INC
Reel/Frame 044828/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2016
From: ANGIOMEDX, INC.
To: SUMMERS, DAVID P
Reel/Frame 039671/0211 →
Continuity (3)
Provisional Application 6040064900 · Aug 2, 2002
Provisional Application 6047513100 · Jun 2, 2003
Related Publication 20040167179A1 · Aug 26, 2004